Clinical Guidelines

The Retina: A Window on Neurodegeneration

New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration

  • By

  • March 9, 2026

  • 7 min

Share

A Cedars-Sinai study published in Nature Communications has identified chlamydia pneumoniae, typically known for respiratory infections, as a potential retinal biomarker for Alzheimer’s disease and other neurodegenerative conditions. The retina, sharing developmental origins with the brain, allows for non-invasive imaging that can track neuroinflammation and degeneration over time. Researchers revealed that the bacterium might act as a provoker of inflammation rather than a passive observer, highlighting its connection to neuronal health. The study paves the way for improved risk assessments and collaborations between ophthalmology and neurology.

Original Source(s)

The Retina: A Window on Neurodegeneration

New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration

  • March 9, 2026

  • 7 min

Related Content

Eric Souied Joins SeaBeLife

French biotechnology company, SeaBeLife, welcomes AMD specialist to its scientific committee

  • March 9, 2026

  • 2 min
Commercial Launch of OS 4 Up

Platform features newly developed Phaco Assisted Cataract Surgery (PACS) modulation

  • March 6, 2026

  • 2 min
Debunking Myths in Eye-Brain Health

Separating hype from clinical reality in AI-powered eye–brain assessment

  • March 6, 2026

  • 6 min